Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Uriage Xémose C8+ Lipid-Replenishing Anti-Itch Balm
- Development stage
- Unknown
- Lead developer
- Uriage
- Administration
- Topical
01
Overview
Uriage Xémose C8+ Lipid-Replenishing Anti-Itch Balm is an over-the-counter dermocosmetic topical balm developed by Uriage Dermatological Laboratories for very dry, sensitive, and atopy-prone skin, including individuals with atopic dermatitis (eczema). Formulated with a proprietary C8+ complex of eight biomimetic ceramides, 10% shea butter, and illipe oil, the balm is designed to restore the skin's physical barrier and replenish essential lipids. It also features two patented complexes: TLR2-REGUL, which targets the immune barrier to calm irritation, and Chronoxine, which provides immediate soothing of itch. By acting on the physical, microbiome, and immune barriers of the skin, the fragrance-free and hypoallergenic balm helps to space out dryness flare-ups and provide long-lasting comfort for the entire family, including infants.
- Brand names
- Uriage Xémose C8+ Lipid-Replenishing Anti-Itch BalmUriage Xémose C8+ Soothing Anti-Scratch BalmXEMOSE C8+ Balm
- Other names
- Uriage Xémose C8+ Anti-scratch balmUriage Xémose C8+ Lipid-Replenishing Balm
02
Targets
TLR2 (Toll-like Receptor 2)
Beyond the preview
Go deeper on Uriage Xémose C8+ Lipid-Replenishing Anti-Itch Balm.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Uriage Xémose C8+ Lipid-Replenishing Anti-Itch Balm.